-
GALEAS™ uPCR: ESR1 – Mutation Testing for ER+/HER2- Breast Cancer through Liquid Biopsy
GALEAS™ uPCR: ESR1High-Sensitivity ESR1 Mutation Detection in ER+/HER2- Breast Cancer Detect ESR1 mutations with high sensitivity and specificity in ER+/HER2- metastatic breast cancer using GALEAS™ uPCR: ESR1. A fast, cost-effective liqu... -
GALEAS™ Bladder – Ultra-Sensitive, Non-Invasive Urine Test for Bladder Cancer
GALEAS™ BladderNon-Invasive Urine Test for Bladder Cancer Detection GALEAS™ Bladder is an advanced NGS-based urine test for bladder cancer detection. It offers high sensitivity, non-invasive sampling, and comprehensive somatic variant re... -
GALEAS™ Tumor – NGS-Based Comprehensive Cancer Profiling
GALEAS™ Tumor Precision Cancer Genomic Profiling with NGS Discover GALEAS™ Tumor, an NGS solution for in-depth cancer genomic profiling, detecting SNVs, CNVs, INDELs, TMB, MSI, and key immuno-oncology biomarkers Advanced NGS-Based Identi... -
Cell3™ Target: Nexome – Clinically Enhanced Exome Capture for SNV, INDEL, and CNV Detection
Cell3™ Target: NexomeComprehensive Exome Capture with Superior Variant Detection Cell3™ Target: Nexome offers enhanced exome capture with precise SNV, INDEL, and CNV detection. Achieve broader variant capture, optimized efficiency, and r...
1